Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control study.
Massih NingarhariMarlène BertezAnne PloquinNicolas BertrandChristophe DesauwStéphane CattanPascale CatalaHélène VandammeClaire CheymolStéphanie TruantGuillaume LassaillyAlexandre LouvetPhilippe MathurinSébastien DharancyAnthony TurpinPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
Chemotherapy should be proposed only in patients with compensated cirrhosis with close monitoring of liver function. Dose management remains challenging. Multidisciplinary management is warranted to improve these patients' outcomes.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- locally advanced
- clinical trial
- papillary thyroid
- peritoneal dialysis
- squamous cell carcinoma
- prognostic factors
- study protocol
- radiation therapy
- cross sectional
- type diabetes
- adipose tissue
- patient reported outcomes
- lymph node metastasis
- chemotherapy induced
- childhood cancer